# huCART19-IL18 in CD19+ Cancers

> **NCT04684563** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 72 (estimated)

## Conditions studied

- Chronic Lymphocytic Leukemia
- Non-hodgkin Lymphoma
- Acute Lymphoblastic Leukemia

## Interventions

- **BIOLOGICAL:** huCART19-IL18

## Key facts

- **NCT ID:** NCT04684563
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-05-06
- **Primary completion:** 2036-05
- **Final completion:** 2036-05
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2025-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04684563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04684563, "huCART19-IL18 in CD19+ Cancers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04684563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*